Creatine and Ozempic: Safety and Kidney Function Guide

Last reviewed: May 17, 2026

Last updated: May 17, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Yes, creatine can typically be taken with Ozempic, but kidney function monitoring becomes critical. GLP-1 medications increase dehydration risk, and creatine supplementation places additional stress on renal filtration—making baseline kidney assessment essential before combining them.

This question matters because many patients starting Ozempic or other GLP-1 therapies also maintain fitness routines involving creatine supplementation. PlexusDx emphasizes precision wellness: understanding your individual metabolic and renal predispositions helps your provider make safer, more personalized recommendations about supplement use during treatment.

How GLP-1 Medications Affect Hydration and Kidney Stress

GLP-1 drugs like Ozempic work partly by slowing gastric emptying, reducing appetite, and increasing satiety—which often leads to decreased fluid intake. Studies show GLP-1 users report 15–25% lower daily water consumption than baseline, increasing dehydration risk and raising serum creatinine levels.

Dehydration concentrates creatinine in the bloodstream and reduces glomerular filtration rate (GFR), the key measure of kidney function. When creatine supplementation is added to this environment, the kidneys must work harder to excrete both endogenous creatinine and exogenous creatine, potentially accelerating renal stress in susceptible individuals.

Creatine, Kidney Function, and GLP-1 Interaction Framework

Evaluating safety requires assessing baseline kidney health, current hydration patterns, and individual renal risk factors. The framework below outlines key considerations for patients considering creatine while on Ozempic or compounded GLP-1 therapies.

Consideration	Clinical Relevance
Baseline GFR or eGFR	GFR >60 mL/min/1.73m² generally supports creatine use; <45 may contraindicate it
Serum Creatinine Trend	Rising creatinine on GLP-1 alone warrants caution; may indicate dehydration or early renal stress
Daily Fluid Intake	Creatine users need 2.5–3.5 L water daily; GLP-1 therapy often reduces natural thirst cues
Electrolyte Status	GLP-1-induced nausea and reduced intake can lower sodium, potassium; creatine further concentrates urine
Concurrent Medications	NSAIDs, ACE inhibitors, or diuretics amplify renal stress risk when combined with creatine and GLP-1

Evidence on Creatine Safety in Healthy Individuals vs. GLP-1 Users

In healthy adults with normal kidney function, creatine monohydrate (3–5g daily) has a strong safety record spanning 30+ years of research. However, GLP-1 therapy creates a different physiological context: reduced hydration, potential electrolyte shifts, and baseline metabolic changes that may alter creatine metabolism.

No prospective studies directly examine creatine + GLP-1 safety. Retrospective data suggests risk is low in well-hydrated patients with GFR >60, but patients with baseline hypertension, diabetes, or family history of kidney disease should obtain baseline and quarterly renal labs (creatinine, BUN, eGFR, electrolytes) before starting creatine.

Who Should Avoid Creatine on Ozempic and Provider Guidance

Patients with eGFR <45 mL/min/1.73m², history of acute kidney injury, or uncontrolled hypertension should avoid creatine supplementation entirely while on GLP-1 therapy. Additionally, individuals who struggle to maintain adequate hydration—whether due to nausea, gastroparesis, or cognitive factors—carry higher risk and should discuss alternatives with their provider.

Before starting creatine with Ozempic or compounded GLP-1 medications, schedule a renal function panel and discuss hydration benchmarks with your healthcare team. A qualified provider can assess whether your baseline kidney health, medication regimen, and lifestyle support safe creatine use, or whether alternative supplements better suit your situation.

How PlexusDx Supports a More Personalized Approach

PlexusDx's Precision Peptide Genetic Test may help provide context around individual variations in kidney function, electrolyte handling, and metabolic stress response. Genetic predispositions in renal pathways (though not yet fully characterized in commercial testing) can support a more informed conversation with your provider about whether creatine supplementation aligns with your baseline renal reserve.

The PlexusDx Precision Peptide Genetic Test analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Ozempic or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

If you're considering compounded GLP-1 therapy (semaglutide, tirzepatide, or microdose protocols) alongside fitness supplements, discussing your genetic and metabolic profile with a PlexusDx-affiliated provider can support a more personalized safety conversation. This approach ensures your supplement strategy aligns with your individual kidney function and GLP-1 treatment goals.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Oral is $349/mo month-to-month, or from $279/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

What is the article's core concern about combining creatine with a GLP-1 medication?

Kidney function. The post says GLP-1 medications raise dehydration risk while creatine supplementation adds to renal filtration demand, so baseline kidney assessment matters before combining them. It explains that dehydration concentrates creatinine and reduces glomerular filtration rate, which is the measure providers watch. It frames the combination as usually workable but requiring monitoring.

Why does the article say people on these medications end up drinking less?

The post says slowed gastric emptying, reduced appetite, and increased satiety often lead to lower fluid intake, and that the medications blunt natural thirst cues. It attaches a specific percentage drop in daily water consumption to that claim without naming the studies behind it, so treat that figure as unverified. The direction of the effect, rather than the number, is what its argument rests on.

What kidney function thresholds does the article use for this decision?

The post says a GFR above 60 mL/min/1.73m2 generally supports creatine use, while below 45 may rule it out. It says patients with an eGFR under 45, a history of acute kidney injury, or uncontrolled hypertension should avoid creatine entirely while on GLP-1 therapy. It also flags a rising creatinine trend on the medication alone as a reason for caution.

Is there direct research on taking creatine alongside a GLP-1, according to the article?

No. The post states plainly that no prospective studies directly examine creatine and GLP-1 safety together. It contrasts that with creatine monohydrate at 3 to 5 grams daily in healthy adults, which it says has a safety record spanning more than 30 years of research. Its claim about supportive retrospective data is not attributed to a named source.

Which other medications does the article say raise the risk in this combination?

The post names NSAIDs, ACE inhibitors, and diuretics as amplifying renal stress risk when combined with creatine and a GLP-1. It separately notes that nausea and reduced intake can lower sodium and potassium, while creatine further concentrates urine. It recommends a renal function panel and a hydration discussion with the healthcare team before adding the supplement.

Related Reading

• Ozempic For Weight Loss 2
• Average Weight Loss On Ozempic
• Weight Loss Drugs Like Ozempic
• Ozempic Weight Loss Before And After Pictures

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.